Literature DB >> 22385608

Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk.

Chia-Chi Wang1, Tai-Chung Tseng, Tsung-Cheng Hsieh, Ching-Sheng Hsu, Pin-Chao Wang, Hans Hsienhong Lin, Jia-Horng Kao.   

Abstract

Non-alcoholic fatty liver disease is associated with an increased risk of metabolic and cardiovascular diseases. Whether the severity of fatty liver on ultrasound correlates with metabolic or cardiovascular risk remains unclear. A total of 1000 people receiving health examinations were enrolled, and 126 were excluded due to the presence of HBsAg, anti-HCV, known hepatic disorders or alcohol use (>140 g/wk). Significant fatty liver consisted of moderate and severe fatty liver on ultrasound. The definition of central obesity was modified to a waist circumference of >90 cm in men and >80 cm in women. Framingham risk score was used to estimate the risk of cardiovascular disease. A total of 874 subjects (485 women and 388 men with a mean age of 52.07 ± 11.68 years) were included in the final analysis. By using logistic regression analyses stratified by gender, the odds ratio for the prevalence of diabetes mellitus, metabolic syndrome and risk of cardiovascular disease increased with increasing fatty liver status in both genders (p ≤ 0.001). The difference was not only present between individuals with fatty liver vs. non-fatty liver but also between the mild fatty liver and significant fatty liver groups (p < 0.05). In conclusion, the severity of fatty liver on ultrasound could be useful for the risk stratification of metabolic syndrome, diabetes mellitus and cardiovascular disease in clinical practice. Copyright Â
© 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22385608     DOI: 10.1016/j.kjms.2011.10.005

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  6 in total

1.  Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.

Authors:  Christopher Leung; Sern Wei Yeoh; Desmond Patrick; Shara Ket; Kaye Marion; Paul Gow; Peter W Angus
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 3.  Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review.

Authors:  Reza Karbasi-Afshar; Amin Saburi; Hossein Khedmat
Journal:  J Tehran Heart Cent       Date:  2014-01-12

4.  Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients.

Authors:  Ka Shing Cheung; Lok Ka Lam; Rex Wan Hin Hui; Xianhua Mao; Ruiqi R Zhang; Kwok Hung Chan; Ivan Fn Hung; Wai Kay Seto; Man-Fung Yuen
Journal:  Clin Mol Hepatol       Date:  2022-05-11

5.  Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients.

Authors:  Jee-Fu Huang; Ming-Lun Yeh; Ming-Lung Yu; Chung-Feng Huang; Chia-Yen Dai; Ming-Yen Hsieh; Meng-Hsuan Hsieh; Ching-I Huang; Zu-Yau Lin; Shinn-Chern Chen; Pi-Jung Hsiao; Shyi-Jang Shin; Wan-Long Chuang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

6.  Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease.

Authors:  Sumitro Kosasih; Wong Zhi Qin; Rafiz Abdul Rani; Nazefah Abd Hamid; Ngiu Chai Soon; Shamsul Azhar Shah; Yazmin Yaakob; Raja Affendi Raja Ali
Journal:  Int J Hepatol       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.